Sign up Australia
Proactive Investors - Run By Investors For Investors

Sigma Healthcare's continued challenges further impact revenue projections

Sigma shares have fallen 3.8% to A$0.895 in the first minutes of trade.
Doctor and patient
Profits will be lower

Sigma Healthcare Ltd (ASX:SIG) shares have already been battered in the past couple of months, as the company outlined sales challenges.

Sigma closed yesterday at A$0.93, an improvement from the recent 12-month low of A$0.73, but well down from the high of A$1.53 late in 2016 before the problems were known to the market.

The company has today outlined further challenging general industry conditions.

Sigma now anticipates that 1H18 underlying EBIT will be around A$44mln, with FY2018 underlying EBIT expected to be around A$90mln.

This compares to current market consensus for FY18 of circa A$95mln underlying EBIT.

Mark Hooper, CEO and managing director, commented: "Sigma delivered above guidance growth in FY17 and remains confident that our business strategy and increased investment in infrastructure will deliver growth and efficiency improvements beyond the current year."

Register here to be notified of future . Company articles
View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

learning symbol on a keyboard
January 17 2017
The English language learning specialist is confident it can kick on in the coming year
picture of text
July 28 2017
Dotdigital ha been named as one of the fastest growing companies in Europe
February 21 2017
One particular development of note is Cello Pulsar, a social media analytics tool that has, according to the experts, the potential to be a real winner.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use